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Snap25S187A/S187A mouse  is a knock-in  mouse  with  a  single  amino  acid  substitution  at a  protein  kinase
C-dependent  phosphorylation  site  of the  synaptosomal-associated  protein  of  25  kDa  (SNAP-25),  which
is a target-soluble  NSF  attachment  protein  receptor  (t-SNARE)  protein  essential  for neurotransmitter
release.  Snap25S187A/S187A mice  exhibit  several  distinct  phenotypes,  including  reductions  in dopamine  and
serotonin  release  in  the  brain, anxiety-like  behavior,  and  cognitive  dysfunctions.  Homozygous  mice  show
spontaneous  epileptic  convulsions,  and  about  15% of the  mice  die  around  three weeks  after  birth.  The
remaining  mice  survive  for  almost  two  years  and  exhibit  spontaneous  recurrent  seizures  throughout
their  lifetime.  Here,  we  conducted  long-term  continuous  video  electroencephalogram  recording  of the
mice  and  analyzed  the  process  of  epileptogenesis  and  epileptic  maturation  in detail.  Spikes  and  slow-
wave  discharges  (SWDs)  were  observed  in the  cerebral  cortex  and  thalamus  before  epileptic  convulsions
began.  SWDs  showed  several  properties  similar  to  those  observed  in  absence  seizures  including  (1)  lack
of in the  hippocampus,  (2) movement  arrest  during  SWDs,  and  (3)  inhibition  by  ethosuximide.  Multiple
generalized  seizures  occurred  in all homozygous  mice  around  three  weeks  after  birth.  However,  seizure
generation  stopped  within  several  days,  and  a seizure-free  latent  period  began.  Following  a  spike-free
quiet  period,  the  number  of spikes  increased  gradually,  and  epileptic  seizures  reappeared.  Subsequently,
spontaneous  seizures  occurred  cyclically  throughout  the  life  of  the  mice,  and  several  progressive  changes
in  seizure  frequency,  seizure  duration,  seizure  cycle  interval,  seizure  waveform,  and the  number  and
waveform  of  epileptic  discharges  during  slow-wave  sleep  occurred  with  different  time  courses  over  10
weeks. Anxiety-related  behaviors  appeared  suddenly  within  three  days  after  epileptic  seizures  began  and
were delayed  markedly  by oral  administration  of  valproic  acid.  These  results  showed  that  Snap25S187A/S187A
mice  exhibited  a variety  of epilepsy-related  phenomena,  and  thus,  they  will  be  useful  for  understanding
the  mechanisms  of epileptogenesis,  epileptic  maturation,  and  the  actions  of antiepileptic  drugs.
© 2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-NDAbbreviations: A, anterior; AED, antiepileptic drug; BDNF, brain-derived neurotroph
brillary  acidic protein; GS, generalized seizure; L, lateral; NPY, neuropeptide Y; P, poster
∗ Corresponding author. Tel.: +81 42 778 8626 (ofﬁce); +81 42 778 9548 (lab); fax: +81
E-mail addresses: nabesige@kitasato-u.ac.jp (S. Watanabe), yamamori@med.kitasato-
M.  Saito), e-suzuki@iuhw.ac.jp (E. Suzuki), mars@shinshu-u.ac.jp (M.  Kataoka), miyaoka@
1 These three authors contributed equally to this work.
2 Current address, Department of Neurophysiology, School of Medicine, Keio Universit
ttp://dx.doi.org/10.1016/j.eplepsyres.2015.05.004
920-1211/© 2015 The Authors. Published by Elsevier B.V. This is an open access article 
/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ic factor; D, dorsal; EEG, electroencephalogram; ESM, ethosuximide; GFAP, glial
ior; SNAP-25, synaptosomal-associated protein of 25 kDa; VPA, valproic acid.
 42 778 8441.
u.ac.jp (S. Yamamori), otsuka@z6.keio.jp (S. Otsuka), 7n2ecx@mtf.biglobe.ne.jp
med.kitasato-u.ac.jp (H. Miyaoka), masami@med.kitasato-u.ac.jp (M.  Takahashi).
y, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
sy Res
I
b
i
t
7
r
t
a
d
p
t
(
i
t
i
b
c
a
a
m
d
t
a
a
r
E
o
a
F
s
t
o
q
t
i
t
m
h
b
M
S
a
t
d
2
L
2
K
F
m
r
e
m
t
n
t
e
2
m
t
P
pS. Watanabe et al. / Epilep
ntroduction
Epilepsy, a chronic neurological disorder that is characterized
y recurrent spontaneous seizures due to neuronal hyperactivity
n the brain, is the most common serious neurological condi-
ion, affecting more than 50 million people world-wide. Between
0% and 80% of people with epilepsy go into remission, and the
emaining patients will continue to have seizures and will be resis-
ant to antiepileptic drugs (AEDs). Thus, development of new AEDs
nd new method of treatment are urgently required. Much evi-
ence exists to support the view that development of epilepsy is a
rocess that should be treated as early and effectively as possible
o try to prevent the development of chronic, intractable epilepsy
Reynolds, 1995). Administration of proper doses of proper med-
cations at a proper time is required for effective treatment, and
hus, understanding the molecular and neuronal basis of epilepsy
s important. Acquisition of epilepsy is thought to arise from a
rain insult such as traumatic brain injury, stroke, status epilepti-
us, or infection/inﬂammation, and spontaneous recurrent seizures
re thought to occur after a latent period. Acquired epilepsy is
lso often considered to be progressive, with seizures that occur
ore frequently and that increase in severity over time. These two
istinct processes are designated “epileptogenesis” and “epilep-
ic maturation”, respectively (Pitkänen and Sutula, 2002; Dudek
nd Staley, 2011a, b). To study the processes of epileptogenesis
nd epileptic maturation, continuous electroencephalogram (EEG)
ecording is inevitably necessary. However, obtaining continuous
EG records of human patients from the time of brain insult to the
nset of clinical seizures is difﬁcult because seizures are often initi-
ted over a long period, ranging from several months to many years.
urthermore, many human patients receive AEDs to suppress the
ymptomatic or “early” seizures that are directly associated with
he brain injury, and most patients are treated with AEDs after
ne or a few “late” (i.e., “epileptic”) clinical seizures. Therefore,
uantitative analysis of the temporal features of acquired epilep-
ogenesis in humans independent of the effects of AEDs is nearly
mpossible. Thus, adequate animal models of epilepsy are necessary
o understand the neuronal basis of epileptogenesis and epileptic
aturation.
To date, many mutant mice with spontaneous epileptic seizures
ave been established using either gene engineering techniques or
y isolating spontaneous mutants (Steinlein and Noebels, 2000;
eisler et al., 2001; Crunelli and Leresche, 2002; Upton and
tratton, 2003; Baraban, 2007; Zhu et al., 2008). Animal models of
cquired epilepsy have also been developed based on status epilep-
icus that is induced with administration of a chemo-convulsant
rug (Coulter et al., 2002; Morimoto et al., 2004; Curia et al.,
008; Scorza et al., 2009), electrical stimulation (Kalynchuk, 2000;
öscher, 2002; Morimoto et al., 2004; Sloviter and Bumanglag,
013), or hypoxic–ischemic brain injury (Williams et al., 2009;
adam et al., 2010). However, all models have some shortcomings.
or example, some mice have a high mortality rate; epileptic ani-
als are time consuming and labor intensive to establish; animals
epresent only the restrictive phenotype of epilepsy, etc. Because
pilepsy is a heterogeneous disorder with multiple origins and
any different mechanisms of pathogenesis among patients, mul-
iple animal models with different origins and phenotypes are
ecessary to understand epileptogenesis and epileptic maturation.
The synaptosomal-associated protein of 25 kDa (SNAP-25) is a
arget-soluble NSF attachment protein receptor (t-SNARE) protein
xpressed in neurons and some secretory cells (Jahn and Fasshauer,
012; Südhof, 2013). SNAP-25 plays essential roles in neurotrans-
itter release and incorporation of ion channels and receptors into
he plasma membrane by exocytosis (Jarvis and Zamponi, 2007;
ozzi et al., 2008; Selak et al., 2009; Lau et al., 2010). SNAP-25 is
hosphorylated by protein kinase C (PKC) at Ser187 (Shimazaki et al.,earch 115 (2015) 30–44 31
1996), and mutant mice with the single amino acid substitution
S187A show very strong anxiety-like behaviors and cognitive dys-
functions (Kataoka et al., 2011, Ohira et al., 2013). Interestingly, all
mutant mice have recurrent spontaneous epileptic seizures around
three weeks after birth (Kataoka et al., 2011). Despite repetitive
epileptic seizures that occur throughout the lifespan of the mutant
mice, the mice survive nearly 2 years, and thus, following the pro-
cesses of epileptogenesis and epileptic maturation throughout life
is possible. Here, we conducted continuous long-term video-EEG
recording of Snap25S187A/S187A mice. We  also examined the effect of
epileptic seizures on anxiety-like behaviors.
Materials and methods
Animals
All procedures involving animals complied with the guidelines
of the National Institutes of Health and were approved by the
Animal Experimentation and Ethics Committees of the Kitasato
University School of Medicine. All efforts were made to mini-
mize animal suffering and reduce the number of animals used.
Snap25S187A/S187A mice were generated as described previously
(Kataoka et al., 2011). Mice heterozygous at the Snap25S187A locus
were bred with C57BL/6 N mice (CLEA, Japan) and maintained using
standard husbandry procedures. After back-crossing the mutant
mice onto the C57BL/6 N genetic background 13 times, homozy-
gous mice were routinely obtained with in vitro fertilization using
ICR mice as foster mothers. They were maintained in a 14:10-h
light–dark cycle with lights on beginning at 6:00 a.m. under con-
stant temperature (23 ± 1 ◦C) in a room with a clean air conditioning
system. One week before the ﬁrst behavior experiment, they were
handled once daily for three days.
Surgery
Under sevoﬂurane inhalation anesthesia (3–4% sevoﬂu-
rane/oxygen ﬂow 0.5 L/min) and subcutaneous injection of
xylocaine, the mice were implanted with EEG and electromyogram
electrodes. Bipolar electrodes (two stainless steel wires, 0.2 mm
in diameter, tip separation 0.5 mm)  were implanted in either the
left dorsal hippocampus at posterior (P): 2.0 mm (from bregma),
lateral (L): 1.4 mm (from the midline), and dorsal (D): −2.1 mm
(from the dura) or the ventral posteromedial thalamic nucleus of
the left thalamus at P: 2.2 mm (from bregma), L: 1.4 mm (from
the midline), and D: −4.0 mm (from the dura). Three stainless
steel miniature screws (1.0 mm),  which served as epidural EEG
electrodes, were placed over the left frontal cortex [anterior (A):
1.2, L: 1.0], right anterior region for the reference electrode (A: 2.5,
L: 0.6), and right occipital region for the ground electrode (P: 2.5, L:
2.0). In addition, two  Teﬂon® insulated stainless steel micro-wires
were inserted bilaterally and subcutaneously into the dorsal neck
to record electromyograms. Dental cement was used to fasten the
micro-connection socket to the surface of the skull. EEG recording
was started on the day of surgery.
Electroencephalographic recordings
The hippocampal and thalamic EEGs were recorded between
the long and short bipolar electrodes, and the cortical EEG was
recorded between the anterior and frontal cortical screw elec-
trodes. The signal from the recording electrodes was ampliﬁed and
ﬁltered (Time Constant: 0.01 s, high cut: 30 Hz). In addition, a 50-
Hz notch ﬁlter was  applied. The ampliﬁed signal was digitized at
500 Hz with a data translation A/D board and was  recorded directly
onto a PC hard drive using Multi Scope 2100 (Medical Try System).
Simultaneously with the EEG recording, all mice were continuously
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ideo-monitored using two CCD cameras set in the diagonal direc-
ion during the experimental periods. Cameras were capable of
nfrared recording during the dark phase. Mice were housed with
ree access to food and water in clear plastic cages (one per cage)
o allow optimal video observation in a sound-attenuating box.
hey were maintained in a 12:12-h light–dark cycle with lights
n beginning at 8:00 a.m. The EEG recording was interrupted from
9:00–10:00 for cage cleaning and feeding.
nalysis of EEG data
All EEG data were analyzed with Multi Scope 2100 software.
ecause the absolute value of the EEG data varied among differ-
nt mice and different experimental days, possibly due to different
lectrode conditions, a standard value for normalization was deter-
ined for each mouse on each experimental day. Averaged EEG
alues over 5 min  were measured at ﬁve different time points in
he aroused state each day, and the mean of these values was used
s the standard value of the mouse on that day. For spike counting,
he number of spikes in which the amplitude was  10 times larger
han the standard value was counted. Seizures were identiﬁed with
EG and video monitoring.
rug administration
Ethosuximide (ESM) was dissolved in saline and given to the
ouse by i.p. injection (200 mg/kg). For continuous injection, an
nd of Teﬂon tube (1.0 mm)  ﬁxed onto the socket for the EEG elec-
rode on the skull was inserted into the peritoneal cavity through
he subcutaneous space, and another end was connected with a
yringe pump (KDS-220, KD Scientiﬁc Inc.). The mouse was  given
SM (1000–2000 mg/kg/day) continuously.
For other experiments, after weaning at 16 days old,
nap25S187A/S187A mice and their wild-type littermate controls were
ed powdered mouse chow with or without valproic acid (VPA)
10 g/kg chow before ﬁve weeks old and 20 g/kg chow after).
ntibodies
We  used rabbit anti-glial ﬁbrillary acidic protein (GFAP; Sigma),
abbit anti-neuropeptide Y (NPY; Peninsula Laboratories), HRP-
oat anti-rabbit IgG and HRP-conjugated goat anti-mouse IgG + IgM
ntibodies (Jackson ImmunoResearch). A mouse monoclonal anti-
rain-derived neurotrophic factor (BDNF) antibody, which was
enerated against a synthetic peptide TMDSKKRIGWRFIR (residues
21–234 of rat proBDNF), was a kind gift from Dr. Makoto Itakura
f Kitasato University School of Medicine.
mmunohistochemistry
Mice of various ages were deeply anesthetized with isoﬂu-
ane and transcardially perfused with phosphate-buffered 4%
araformaldehyde. Brains were then removed from the calvaria,
ost-ﬁxed overnight at 4 ◦C in 4% paraformaldehyde, processed for
arafﬁn embedding, and cut at a thickness of 3 m.  For immunohis-
ochemical detection of GFAP and NPY, sections were ﬁrst treated
ith 5 g/ml proteinase K (Dako) for 3 min  at room temperature.
ndogenous peroxidase activity was then inhibited by incubating
he sections in 3% hydrogen peroxide/calcium- and magnesium-
ree phosphate-buffered saline for 5 min. After treatment with
locking buffer (0.5% casein, 0.3 M NaCl, 0.1 M Tris-HCl, pH 7.5),
he sections were incubated overnight at 4 ◦C with anti-GFAP or
nti-NPY antibodies (1:3000), and the immune complexes were
etected using a peroxidase-conjugated Fab’ fragment of anti-
abbit antibody (Nichirei Bioscience), followed by staining with
iaminobenzidine tetrahydrochloride substrate (Dako). In somesearch 115 (2015) 30–44
experiments, we counterstained the sections with hematoxylin
(Vector Lab) after immunostaining.
Western blotting
For western blotting, the hippocampus was removed and
homogenized in 5 ml  SDS sample buffer [70 mM SDS, 3.3% (w/v)
glycerol, 0.03 mM bromophenol blue, 125 mM Tris-HCl, pH 6.8]
in the presence of 20 mM DTT with an ultrasonicator. The sam-
ples were boiled, and the protein concentrations were determined
using the BCA protein assay kit (Pierce). SDS-PAGE was per-
formed on 12.5% or linear 10–20% (w/v) acrylamide gradient
gels. Immunoblotting was performed with enhanced chemi-
luminescence (Amersham) as described previously (Iwasaki et al.,
2000). Anti-GFAP (1:1000), anti-BDNF (10 mg/L), HRP-conjugated
goat anti-rabbit IgG (1:3000), and HRP-conjugated goat anti-mouse
IgG + IgM (1:3000) were used.
Behavior experiments
General activity was measured in an open-ﬁeld box placed
in a sound-attenuated room. Mice were placed in the cen-
ter of a brightly lit (650–700 lx) chamber of the apparatus
(50 × 50 × 40 cm3). Movements of the animals were tracked with
the automatic monitoring system Lime Light (Actimetrics Inc.) for
30 min. Horizontal motor activity (distance traveled) and central
activity (distance traveled in the central area/total distance trav-
eled) were evaluated. The ﬁeld was  divided into 9 × 9 subareas,
and the center area was deﬁned as the inner 8 × 8 subareas. Central
activity was  calculated from the number of crossings in the central
area divided by the number of total crossings.
The apparatus for the light and dark preference test consisted of
two compartments of gray vinylchloride plates and was placed in a
darkened, sound-attenuated room. One compartment was a bright
(250 lx) chamber (25 × 50 × 40 cm3) illuminated with a ﬂuorescent
lamp, and the other was  a dark (0.5 lx) chamber (25 × 50 × 40 cm3).
The two compartments were separated by a wall with a small open-
ing (8 × 16 cm2). Two  pairs of 24 × 24-array infrared photosensors
were attached to the outer wall, equally spaced in rows 2.5 cm
and 6.5 cm from the ﬂoor. The lower row of photocells was used
to detect the location of the mouse, and the upper row was used to
detect rearing behavior. The sensor state was  sampled every 0.1 s.
A mouse was placed in the center of the light chamber facing the
opening, and its behavior was recorded by the computer for 30 min.
The mouse was considered to have entered a new area when the
center of the body was  in this area. The apparatus was  cleaned with
70% ethanol after each trial.
Statistics
Data are shown as the mean ± standard deviation (SD). Two
groups were compared using the two-tailed, unpaired Student’s
t-test. Groups of three or more were analyzed with one-way or
two-way ANOVA tests followed by Tukey-Kramer’s honestly sig-
niﬁcant difference post-hoc test. A p value <0.05 was considered
statistically signiﬁcant.
Results
Epileptogenesis in Snap25S187A/S187A homozygous miceAlthough individual differences were found among Snap25S187A
mice that were back-crossed 13 times onto the C57BL/6 N back-
ground, all Snap25S187A/S187A mice showed essentially the same
sequential process of epileptogenesis. We  designated successive
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eriods in the process as the pre-generalized seizure (GS) period,
rst GS period, latent period, and second GS period.
The youngest mouse from which we obtained continuous video-
EG recording was postnatal day 19 (P19) because the skull
f younger mice was not fully hardened, and attaching chronic
lectrodes onto the head was difﬁcult. No abnormal discharges
n the EEG of the hippocampus were observed at P19, but we
bserved frequent spontaneous bursts of bilateral spikes and
low-wave discharges (SWD) in the cerebral cortex and thala-
us  in all Snap25S187A/S187A mice (Figure 1A and B). The waveform
igure 1. SWDs found in the cerebral cortex and thalamus of Snap25S187A/S187A mice befo
egions  per mouse were performed with unanesthetized, free-moving Snap25S187A/S187A m
nd  25 days [A-2; cerebral cortex (C, red) and thalamus (T, green)]. Expanded EEGs du
ynchronous ﬁring of SWDs appeared in the cerebral cortex and thalamus, but not the hi
lue,  and green lines are the voltage scale of cerebral cortical, hippocampal and thalamic
rom  a pair of recordings from the cerebral cortex (C, red) and hippocampus (H, blue) (lef
eaks  appeared at 6.92 ± 0.71 Hz and at multiple Hz in the cerebral cortex and thalamus, b
f  SWDs by ESM. The number of spikes per minute was  counted, and the average value
njection at the time indicated by the green arrow. Bottom, ESM (1000 mg/kg/day) was giv
uppressed SWD. (For interpretation of the references to color in this ﬁgure legend, the reearch 115 (2015) 30–44 33
frequency of SWDs was 6.92 ± 0.71 Hz (range 6.3–8.2, median 6.6,
n = 7 mice), which was very similar to those observed in other
mutant mice exhibiting SWDs (Crunelli and Leresche, 2002). SWDs
were observed both in the light and dark periods, but SWDs often
appeared in the aroused state or at the onset of slow-wave sleep
(data not shown). The mean duration of the SWDs was  1.73 ± 0.39 s
(range 1.31–2.33, median 1.65, n = 6 mice). SWDs  observed in
Snap25S187A/S187A mice resembled those in absence seizures because
(1) synchronized discharges were observed in the cortex and
thalamus but not the hippocampus (Figure 1A and B), (2) SWDs
re the onset of the ﬁrst GS period. A. Simultaneous EEG recordings from two brain
ice at the age of 23 days [A-1; cerebral cortex (C, red) and hippocampus (H, blue)]
ring the periods indicated by the blue and green lines are shown on the bottom.
ppocampus. The animal displayed brief behavior arrest during SWDs. Vertical red,
 EEGs, respectively. B. The mean power spectrums of EEGs during SWDs obtained
t), and from the cerebral cortex (C, red) and thalamus (T, green) (right). High, sharp
ut not in the hippocampus. The mean values of ﬁve SWDs are shown. C. Suppression
 in every 15 min  + SEM is shown. Top, ESM (200 mg/kg) was given by a single i.p.
en continuously during the period indicated by the green underline. ESM reversibly
ader is referred to the web version of this article.)
34 S. Watanabe et al. / Epilepsy Research 115 (2015) 30–44
Figure 2. Typical process of epileptogenesis in Snap25S187A/S187A mice. A. Continuous video-EEG recording was conducted from P21 to P33, and the numbers of spikes in the
cerebral  cortex (red circles) and hippocampus (blue circles) per hour were plotted against time from P21 to P27. Yellow and blue lines below the horizontal axis indicated
the  light (08:00–20:00) and dark periods (20:00–08:00) of each day. This is a typical example selected from recordings of nine mice. Despite individual differences in the
length  of each period, all mice showed essentially the same process as shown in this ﬁgure. The process can be divided into several characteristic periods. Characteristic
features of each period and abbreviations used in this ﬁgure are as follows: Pre-GS period (Pre-GS), SWDs appeared but GSs had not yet appeared; First GS period (1st GS),
suddenly began at 23.1 ± 3.6 postnatal days after the ﬁrst spontaneous GS and automatically stopped within 41.3 ± 14.8 h. The times of GS ﬁring are indicated by arrows:
Latent period, a period with no GSs. The latent period was divided into three periods: Post-GS hyper-activated period (HA), monophasic and biphasic spikes and spike clusters
were  observed in both the cerebral cortex and hippocampus after the ﬁrst GS period. However, the number of spikes decreased gradually; Quiet period (Q), a period with
few  spikes (fewer than one per min) in the cortex and hippocampus. Suppression seizure, in which a sudden decrease in the amplitude of hippocampal EEG was observed in
seven  out of 10 mice (Purple arrow in Figure 2B, also see Figure 3A); Reactivated period (R1–R4), a period with monophasic and biphasic spikes of large amplitude and spike
bursts  mainly in the cerebral cortex; Second GS period (2nd GS), a period with spontaneous recurrent GSs that continued throughout life. B. A typical example of cortical
(C,  red) and hippocampal (H, blue) EEGs of GSs during the ﬁrst GS period. C. Typical examples of cortical (C, red) and hippocampal (H, blue) EEG waveforms that appeared
d n tria
a espec
i
d
w
t
v
r
a
c
iuring  each period as shown in A. Time expansion of ictal spikes marked with gree
re  the voltage scale of cerebral cortical (200 V) and hippocampal EEGs (300 V), r
s  referred to the web version of this article.)
isappeared following injection of ESM (Figure 1C), and (3) SWDs
ere accompanied by behavioral arrest. SWDs disappeared with
he onset of GSs during the ﬁrst GS period (data not shown).
All Snap25S187A/S187A homozygous mice suddenly exhibited con-
ulsive seizures around three weeks after birth (23.1 ± 3.6 days,
ange 19–30, median 23, n = 17 mice) without any auras (Figure 2A
nd B). The ﬁrst seizure seemed to be generalized because syn-
hronized seizures were observed in multiple sites in the brain
ncluding the cerebral cortex, hippocampus, and thalamus (Figurengles is shown on the right. Vertical red and blue lines on the right of EEG records
tively. (For interpretation of the references to color in this ﬁgure legend, the reader
S1) and were always accompanied by convulsions. The severity
of the convulsions varied among the ensuing seizures, and some
seizures were not accompanied by convulsions. GSs often appeared
in the beginning of slow-wave sleep (data not shown). This ﬁrst
period of GS generation was relatively short, lasting on average
41.3 ± 14.8 h (range 17–59, median 43, n = 8 mice). The total num-
ber of GSs during this ﬁrst GS period varied with an average of
45.6 ± 19.1 times/ﬁrst GS period (range 21–81, median 46.5, n = 8
mice).
S. Watanabe et al. / Epilepsy Research 115 (2015) 30–44 35
Figure 3. Unusual hippocampal seizures appeared during the latent period. A. Sup-
pression seizure. A-1, EEG waveform of the cerebral cortex (C, red) and hippocampus
(H, blue) during a suppression seizure. A-2, averaged value of EEG amplitude during
the period indicated with the purple line in A-1 was  calculated every 2 min  for the
cerebral cortex (red) and hippocampus (blue) and was plotted against time as the
relative value to the initial value. The amplitudes of cortical EEGs remained constant,
whereas that of hippocampal EEGs decreased with a half-life of 8.9 s. The suppres-
sion seizure appeared only during the latent period and was  observed in seven out
of  10 mice tested. B. High-frequency hippocampal discharge. Expanded EEGs during
the  period indicated with the green lines (a and b) are shown on the bottom. The
seizure was composed of periodic discharge of spike complex and appeared only in
the hippocampus and not in the cerebral cortex. The high-frequency hippocampal
discharge appeared only during the latent period and was observed in four out of
10 mice tested. Vertical red and blue lines are the voltage scale of cerebral cortical
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Figure 4. A. Cyclic changes in GS number during the second GS period. Left, A typ-
ical example of GS generation during the second GS period. Continuous video-EEG
recording was performed in one Snap25S187A/S187A mouse from P22 to P85, and the
GS  number per day was plotted against postnatal day. Right, the peak interval of GS
(average ± SD) in different ages of mice. <11 weeks, 5–11 weeks old, n = 9 in 2 mice;
<43 weeks, 30–43 weeks old, n = 4 in 6 mice; <73 weeks, 70–73 weeks old, n = 4 in 2
mice. Statistical analysis was performed with one-way ANOVA followed by Tukey-
Kramer’s honestly signiﬁcant difference post-hoc test. B. Number of GSs per day at
different postnatal ages. Left, average number of GSs per day (n = 4–17/mouse) was
calculated at various postnatal days in 19 mice and was plotted against postnatal
days. Right, average number of GSs per day at different ages. <4 weeks, 5.6 ± 1.8
(average ± SD, n = 6 mice); >10 weeks, 14.7 ± 3.0 (average ± SD, n = 15 mice). Statis-
tical analysis was performed with the Student’s t-test. C. Duration of GSs. Left, GS
duration was measured (n = 12–69 GS/mouse) in 19 mice, and the means were plot-
ted  against postnatal days. Right, average value of GS duration at different ages. <11nd  hippocampal EEGs, respectively. (For interpretation of the references to color
n  this ﬁgure legend, the reader is referred to the web version of this article.)
Following the ﬁrst GS period, a GS-free latent period appeared
Figure 2A). Although individual variations were present in the
uration of the latent period (105.4 ± 29.6 h, range 63–147, median
02, n = 7 mice) and in the appearance of spike discharges, all mice
howed essentially the same latent period. Even after ceasing GSs,
pike discharges continued for a while (57.3 ± 35.6 h, range 14–118,
edian 62, n = 7 mice) in both the cerebral cortex and hippocampus
ith a gradual decline in frequency (Figure 2A, post-GS hyper-
ctivated period, HA). Following HA, a quiet period (Q) appeared
n all Snap25S187A/S187A mice (Figure 2A and C) during which no
pike discharges were observed in the cerebral cortex or hippocam-
us. A large variation in duration of the quiet period was also
bserved (25.7 ± 12.8 h, range 7–44, median 26, n = 7 mice). Spike
ischarges reappeared prior to regeneration of GSs at the onset of
he second GS period (Figure 2A, reactivated period, R1–4) with a
uration of 22.4 ± 19.2 h (range 2–47, median 13, n = 7 mice). Both
nipolar and bipolar spikes with large amplitudes were observed
uring the latent period except for the quiet period (Figure 2C).
wo types of hippocampal seizures sometimes appeared during
he latent period, including suppression seizures (purple arrow
n Figure 2C and Figure 3A) and high-frequency hippocampal dis-
harges (Figure 3B), which were observed in 7/10 and 4/10 mice,
espectively.weeks, 19.6 ± 1.6 (average ± SD, n = 6 in 5 mice); <43 weeks, 26.8 ± 6.4 (average ± SD,
n  = 12 in 10 mice). p = 0.0162 (Student’s t-test).
After the latent period, GSs again appeared frequently, and the
brain appeared to be fully epileptic (second GS period, Figure 2A,
second GS). The average age of onset of the second GS period was
P30.2 ± 2.9 (range 26–36, median 29.5, n = 14 mice). In striking con-
trast to the ﬁrst GS period, appearance of GSs during the second
GS period did not stop automatically and continued through-
out the mouse’s life. The number of spontaneous GSs every day
changed cyclically (Figure 4A, left) as reported in a pilocarpine
model (Gofﬁn et al., 2007; Mazzuferi et al., 2012). GSs  appeared
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Figure 5. A. Time of occurrence of GSs during the day was plotted with red circles in six sets of four successive days for the mouse shown in Figure 4A. Postnatal day is shown
on  the left. Yellow and blue bars on the bottom indicate the light period (from 08:00 to 20:00) and dark period (from 20:00 to 08:00), respectively. GSs appeared both during
the  light period and dark period, but they tended to appear in clusters on the day of the peak in GS number (P29, P38, P50, P63, and P79). GSs were less frequent on the next
day.  B. EEG proﬁles of the cerebral cortex (C, red) and hippocampus (H, blue) during the periods indicated with the two blue lines (a and b) in Figure 5A at P58. No cortical
spikes  were observed, even 3 h after a cluster of GSs. Arrows at P80 indicate the times of EEG recordings shown in Figure 7A. Vertical red and blue lines are the voltage scale
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Gf  cerebral cortical and hippocampal EEGs, respectively. (For interpretation of the 
rticle.)n both the light and dark periods, but sometimes GSs appeared
n a cluster, especially on the peak day of GS generation in the
ycle (Figure 5A; P29, P50, P58, P63, and P79). We  observed 18
Ss at the most in 10 min. Interestingly, a quiet period with nonces to color in this ﬁgure legend, the reader is referred to the web version of thisseizures and no spikes appeared several hours after the GS cluster
(Figure 5B). GS generation tended to be spread out over most of the
day on the next day of GS clusters (Figure 5A; P51, P59, P64, and
P80).
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Figure 6. Progressive changes in GS waveforms. GSs were composed of two phases, an early phase and a later phase. A remarkable change in the waveform compared to
the  preceding phase was seen. A. Top, typical waveform of EEG that was dominant in young mice. C, cerebral cortex (red); H,  hippocampus (blue). The region marked with
the  green line is expanded on the bottom left. The early phase of this type was composed of continuous irregular spikes. Bottom right, power spectrum of cortical (red) and
hippocampal EEG (blue) in the region marked with the green line in the top chart. No sharp peak was  observed. Vertical red and blue lines are the voltage scale of cerebral
cortical  and hippocampal EEGs, respectively. B. Top, typical waveform of EEG that was dominant in older mice. C, cerebral cortex (red); H, hippocampus (blue). The region
marked with the green line is expanded on the bottom left. Bottom right, power spectrum of cortical (red) and hippocampal EEG (blue) in the region marked with the green
line  in the top chart. The early phase of this type of GS was  composed of continuous monotonic spikes. A very sharp peak appeared at 16 and 33 Hz in the power spectrum.
Vertical red and blue lines are the voltage scale of cerebral cortical and hippocampal EEGs, respectively. C. Power spectrums of the selected period (2 s) in the early phase of
the  EEG were obtained from 10 mice of various ages. Fourteen to 44 power spectrums were obtained per mouse. GSs were classiﬁed into three groups, and their ratio was
represented as the percentage of total GSs in each mouse. The ratio was  at two different ages in two mice. GS was judged to have synchronized in the early phase if the peak
value  of the power spectrum was more than 5%. White box, GS with no synchronization in the early phase; gray box, GS with a synchronized early phase in either the cortex
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emarkably between 3 and 10 weeks after birth. (For interpretation of the reference
rogress in epileptic maturation
Snap25S187A/S187A mice continued to exhibit epileptic spikes and
Ss over their entire lifespan. However, several distinct progres-
ive changes in the EEG proﬁle were observed. The peak interval
f the GS cycle was 8.2 ± 1.8 days (range 5–11, n = 9 in 2 mice)
or mice younger than 11 weeks old, but it decreased with age
nd was 4.4 ± 1.7 days (range 2–7, n = 9 in 6 mice, p = 0.0003)
nd 2.8 ± 1.0 days (range 2–4, n = 4 in 2 mice, p = 0.0001) for mice
t 30–43 and 70–73 weeks old, respectively (Figure 4A, right).
n the other hand, the number of GSs per day increased signiﬁ-
antly (p < 0.00001) between 5 and 10 weeks after birth [5.6 ± 1.8
imes/day (n = 6 mice) and 14.7 ± 3.0 times/day (n = 15 mice) for
ice less than 5 weeks old and older than 10 weeks old, respec-
ively] (Figure 4B). Age-dependent dramatic changes were also seen
n the waveform of GSs. Seizures with longer durations appeared in
ice older than 10 weeks (Figure S2), and the average seizure dura-
ion increased signiﬁcantly (p = 0.0162) from 19.6 ± 1.6 s (n = 6 in 5
ice) to 26.8 ± 6.4 s (n = 12 in 10 mice) between 10 and 20 weeks ofex and hippocampus. The ratio of GSs with a synchronized early phase increased
olor in this ﬁgure legend, the reader is referred to the web version of this article.)
age (Figure 4C). Furthermore, a striking change in the shape of GS
discharges occurred between 3 and 10 weeks after birth. A typical
waveform of GS was composed of two  phases, an early phase that
was composed of continuous spike-wave discharges with variable
amplitudes, and a later phase that was composed of spike clus-
ters separated by suppressed periods (Figure 6A, upper). In mice
younger than four weeks, the early phase of a large population
of epileptic seizures was  composed of continuous spike-wave dis-
charges with variable amplitudes (Figure 6A, bottom left), and no
prominent peak was observed in the power spectrum of the pre-
ceding phase (Figure 6A, bottom right). In contrast, GSs  of the mice
older than four weeks often showed an early phase composed of
very regular monotonic waves (Figure 6B, upper) and prominent
peaks that appeared in the power spectrum (Figure 6B, bottom
right). The percentage of seizures with a monotonic phase increased
remarkably between 3 and 10 weeks after birth (Figure 6C).
A striking progressive change in spikes during slow-wave sleep
occurred in the cerebral cortex and hippocampus over time. Spikes
with large amplitudes often appeared in the hippocampal EEG
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Figure 7. Progressive changes in epileptic spikes during slow-wave sleep. A. A series of EEG records during slow-wave sleep from the cerebral cortex (C, red) and hippocampus
(H,  blue) of the mouse shown in Figure 4A (left) and Figure 5 at various postnatal days. Expanded EEGs during the period indicated with the purple line are shown on the right.
GS  did not occur on P23, P47, or P84, but occurred on P80. EEG records labeled “a” and “b” in P80 were obtained during an intra-GS cluster period and 4.5 h after cessation
of  the GC cluster, respectively, as indicated by the arrows in Figure 5A at P80. In the hippocampus, the number of sharp spikes with high amplitudes increased with age.
However, large-amplitude spikes were rarely observed in the cerebral cortex on days with no GSs. In contrast, hippocampal spikes were observed in clusters separated by
a  refractory period, and synchronized ﬁring of cortical spikes appeared on days with GSs [P80 (a)]. After cessation of the GS cluster, the number of cortical spikes decreased
gradually, and coupling with the hippocampus became less obvious [P83 (b)]. Vertical red and blue lines on the right of EEG records are the voltage scale of cerebral cortical
(100  V) and hippocampal EEGs (500 V), respectively. B. Total number of spikes per day in the cerebral cortex (red circles) and hippocampus (blue circles) in days with no
GS.  Despite the number of hippocampal spikes that increased markedly up to 12 weeks after birth, the number of cortical spikes rarely increased during this period. C. The
total  number of spikes per day in the cerebral cortex (red bars) and hippocampus (blue bars) in days with no GSs at different ages. 3–5 weeks, n = 22 in 7 mice; 6–12 weeks,
n  = 24 in 2 mice; 21–26 weeks, n = 7 in 3 mice; 33–44 weeks, n = 12 in 3 mice; >70 weeks, n = 5 in 2 mice. Statistical analysis was performed using one-way ANOVA followed
by  Tukey-Kramer’s honestly signiﬁcant difference post-hoc test. Spike number in the hippocampus increased signiﬁcantly (p = 0.0002) between 3–5 weeks and 6–12 weeks,
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ahereas that of the cerebral cortex increased between 21–26 weeks and 33–44 w
eader is referred to the web version of this article.)
uring the interictal period (Figure 7A; P47); these were not found
uring the latent period (Figure 7A; P23). Most of these spikes were
iphasic, although monophasic spikes were also observed. The
umber of hippocampal spikes in a GS-free day increased remark-
bly from 3 weeks of age and attained a plateau around 12 weeksp < 0.0001). (For interpretation of the references to color in this ﬁgure legend, the
of age (Figure 7A and B; P84Figure). In contrast, the number of cor-
tical spikes did not signiﬁcantly increase during the same period
(Figure 7A and B; P47 and P84Figure).
The pattern of spike generation was  strongly affected by GSs.
The waveform of hippocampal spikes during slow-wave sleep was
S. Watanabe et al. / Epilepsy Res
Figure 8. Effect of ESM on the onset of the ﬁrst GS period. A. Free-moving mice
with no GSs were continuously given ESM (1000–2000 mg/kg/day) from P20 by i.p.
administration through a Teﬂon tube connected to a syringe pump, and the average
day of the ﬁrst GS was  compared with mice not given ESM. Because some control
mice had already experienced a GS on the ﬁrst day of measurement, the initial day
of  recording was regarded as the onset of GS. A. Average ± SD for ESM-treated (ESM,
green bar, n = 8 mice) and untreated mice (Cont, brown bar, n = 17 mice). p = 0.00011
(Student’s t-test). B. total number of GSs during the ﬁrst GS period was  plotted
against the day of the initial GS for ESM-treated (green triangles) and untreated
mice  (brown circles). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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To investigate the role of multiple epileptic seizures in the
development of anxiety-related behavior, we administered VPA to
wild-type and Snap25S187A/S187A mice beginning at 16 days afteruite different between days with (Figure 7A, P80) and without
Ss (Figure 7A, P84) (see also Figure S3). In days with GSs, multi-
le spikes appeared in a cluster that was separated by refractory
eriods, and synchronized discharge of spike burst was observed
n the cerebral cortex [Figure 7A, P80 (a)]. This characteristic pat-
ern repeated at a frequency of about 0.5 Hz. However, the cyclic
lustering of spikes became less obvious, and the number of cor-
ical spikes decreased gradually after cessation of the GS cluster
Figure 7A, P80 (b)]. In contrast, hippocampal spikes continued to
ppear throughout almost the entire day (Figure S4A). In 42-week-
ld mouse, cortical spikes were also found in the period with no
Ss (Figure S4B). The number of cortical spikes increased remark-
bly around 30 weeks after birth, whereas no signiﬁcant further
ncreases in hippocampal spikes were observed during this period
Figure 7C). Interesting EEG waveforms look like premature form of
S often appeared in days with GSs, which suggested a possibility
hat prolongation of synchronized cortical and hippocampal spike
ischarges may  develop into epileptic seizures (Figure S5).
ffect of ESM on epileptogenesis
As described above, ESM effectively suppressed SWDs during
he pre-GS period. Continuous administration of ESM also sig-
iﬁcantly delayed the appearance of initial GS discharges during
he ﬁrst GS period. The average day of initial GS appearance in
ontrol mice was 23.1 ± 3.6 days (range 19-30, median 23, n = 17
ice), whereas that in ESM-treated mice was 29.6 ± 2.4 days (range
7–34, median 29.5, n = 8 mice) (Figure 8A, p = 0.00011). However,
SM did not inhibit GS generation, and the total number of GSs
uring the ﬁrst GS period was signiﬁcantly (p = 0. 0115) higher
n ESM-treated mice (85.8 ± 34.1, range 41–131, median 86, n = 8
ice) than in control mice (45.6 ± 19.1, range 21–81, median 46.5,
 = 8 mice). Because the number of GSs during the ﬁrst GS period
ended to increase with a delayed onset of initial GSs (Figure 8B),
he apparent increase in the GS number in ESM-treated mice might
ot a primary but a secondary effect of ESM, however, the additional
tudies will be required to clarify this problem.earch 115 (2015) 30–44 39
Progressive changes in brain structure
Histochemical and biochemical analysis revealed that dra-
matic changes in brain structure began to occur around three
weeks after birth in Snap25S187A/S187A mice. NPY immunoreactiv-
ity dramatically increased in several brain regions, including the
hippocampus (Figure 9A) and cerebral cortex (data not shown) of
Snap25S187A/S187A mice. NPY immunoreactivity in the inner molec-
ular layer of the dentate gyrus was  not detected at 10 weeks of
age (Figure 9A-2) but was  detected at 18 weeks of age (Figure 9A-
3, triangles) in Snap25S187A/S187A mice, indicating that a profound
sprouting of mossy ﬁbers occurs at 18 weeks of age but not at 10
weeks of age (see Scharfman et al., 2000; Borges et al., 2003). GFAP
immunohistochemistry revealed many reactive astrocytes in the
hippocampus (Figure 9B) and the cerebral cortex (data not shown)
in Snap25S187A/S187A mice at both 10 (Figure 9B-2) and 18 weeks of
age (Figure 9B-3).
Quantitative immunoblotting revealed no signiﬁcant differ-
ence in hippocampal GFAP expression between wild-type and
Snap25S187A/S187A mice at three weeks after birth; however, GFAP
expression increased thereafter in Snap25S187A/S187A mice and
reached a maximum around 10 to 15 weeks after birth (Figure 9C-1
and C-2). BDNF expression was  also elevated in the hippocam-
pus of Snap25S187A/S187A mice, but was  not signiﬁcantly higher than
in wild-type mice at postnatal day 23. Expression then increased
markedly with development and attained a maximum around 10
weeks after birth (Figure 9C-1 and C-3).
Rapid appearance of anxiety-like behaviors with GSs
Consistent with our previous study (Kataoka et al., 2011),
Snap25S187A/S187A mice exhibited very strong anxiety-related
behavior at ﬁve weeks of age including avoidance of the bright
chamber in the light and dark preference test (Figure S6A) and
thigmotaxis in the open-ﬁeld test (Figure S6B). Surprisingly,
Snap25S187A/S187A mice behaved quite normally at three weeks of
age (Figs. S6A and S6B). To identify the critical period for the dra-
matic change in behavior, we  conducted these behavior tests at
various days after birth. In the light and dark preference test, the
percentage of time wild-type mice remained in the light room was
almost constant throughout the experimental period. On the other
hand, Snap25S187A/S187A mice did not show a strong preference three
weeks after birth, and the value decreased rapidly thereafter (Fig-
ure S6A, bottom). Anxiety-related behavior also appeared during
the same period in the open-ﬁeld test (Figure S6B, bottom).
Because many phenotypes of Snap25S187A/S187A mice appeared
from three weeks onward during the postnatal period, we analyzed
the temporal correlation of epileptogenesis and the appearance of
anxiety-related behavior in mice that did not show anxiety-related
behavior at the beginning of EEG measurement. We  deﬁned the
appearance of anxiety-related behavior as when the percentage of
time at which a Snap25S187A/S187A mouse stayed in the light room
was less than the average value minus 2 SD of wild-type mice.
Figure 10A shows a typical trace. No anxiety-related behavior was
observed at postnatal day 24; however, the mouse had GSs 53 times
between postnatal days 24 and 27. Quite interestingly, the behavior
changed dramatically within only three days of when the repeated
GSs began and showed very strong anxiety-related behavior at day
27 and after. As summarized in Figure 10B, all seven mice had mul-
tiple GSs within three days before demonstrating anxiety-related
behavior. These results suggest that the anxiety-related behavior
in Snap25S187A/S187A mice was  induced by multiple GSs.birth. As shown in Figure 10C-1 and C-2, avoidance of the light
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Figure 9. A and B. Expression of NPY (A) and GFAP (B) in the hippocampus of wild-type mice at 19 weeks of age (A-1 and B-1) and Snap25S187A/S187A mice at 10 (A-2 and B-2)
and  18 weeks of age (A-3 and B-3). Scale bar, 200 m.  Sprouting of NPY-positive mossy ﬁber terminals (marked by triangles) appeared in 18-week-old mice (A-3) but not in
10-week-old Snap25S187A/S187A mice (A-2). On the other hand, reactive astrocytosis was  obvious at 10 weeks of age (B-2). C. Quantiﬁcation of GFAP and BDNF expression in the
hippocampus. (C-1) Immunoblot of hippocampal homogenates from wild-type mice (left two  lanes) and Snap25S187A/S187A mice (right two  lanes) on postnatal day 23 (upper
four  lanes) and postnatal day 79 (lower four lanes) probed with either anti-GFAP or anti-BDNF antibody as indicated on the left. (C-2) Amount of GFAP in the hippocampus
as  determined with quantitation of the immunoblot of wild-type (red circles) and Snap25S187A/S187A mice (blue circles) at various postnatal days. (C-3) Amount of BDNF in the
hippocampus as determined with a quantitative immunoblot of wild-type (red circles) and Snap25S187A/S187A mice (blue circles) at various postnatal days. Values represent
the  mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey-Kramer’s honestly signiﬁcant difference post-hoc test. ***p < 0.0001; **p < 0.001
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netween  wild-type and Snap25S187A/S187A mice of the same age.
oom was markedly suppressed in VPA-treated Snap25S187A/S187A
ice, and the percentage of photobeam crossings in the light room
as comparable to that of wild-type mice at ﬁve weeks of age
Figure 10C-2). In the open ﬁeld test, thigmotaxis was not appar-
nt in VPA-treated Snap25S187A/S187A mice (Figure 10C-3 and C-4).
he suppression was incomplete, and no signiﬁcant difference
as observed between eight-week-old mice with or without VPA
dministration.
iscussion
We  conducted long-term continuous video-EEG recordings of
nap25S187A/S187A mice and found that all mutant mice followed
ssentially the same process of epileptogenesis despite some
ndividual differences. We  also found that the mice demonstrated
pileptic maturation, and several distinct progressive changes
ere identiﬁed in EEG over the 10 weeks after the onset of sponta-
eous GSs. The mutant mice also showed very strong anxiety-likebehaviors after repeated GSs. However, the process proceeded
much faster than epileptic maturation and occurred within a few
days of the onset of GSs.
Three types of epileptic seizures found in Snap25S187A/S187A mice
Snap25S187A/S187A mice showed at least three different types of
epileptic seizures. The ﬁrst type was SWDs, which were observed
as early as 19 days after birth. SWDs showed typical characteristics
of the absence seizures, including (1) a waveform and frequency
of discharge, (2) movement arrest, (3) synchronized ﬁring of the
cortex and thalamus, and (4) sensitivity to ESM. Heterozygous
Coloboma mutant mice with chromosomal deﬁciency in a region
containing Snap25, in which expression of SNAP-25 is half of that
in wild-type mice, exhibit SWDs beginning at 14–15 days after birth
(Zhang et al., 2004). Although the expression level of SNAP-25 in
Snap25S187A/S187A mice is also half that in wild-type mice (Kataoka
et al., 2011), heterozygous Snap25 knock-out mice do not show
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Figure 10. Multiple epileptic seizures precede the rapid appearance of anxiety-related behavior. A. Comparison of traces in the light–dark preference test before and after
the  occurrence of multiple epileptic seizures. The behavior test was conducted in parallel with continuous EEG monitoring. The mouse experienced 53 GSs between postnatal
days  24 and 26, and within three days of seizure onset, showed very strong anxiety-related behavior in the light–dark preference test at postnatal day 27 (0 = normalized day).
B.  The number of generalized epileptic seizures and a measure of anxiety-related behavior (percentage of photobeam crossings in the light room) for seven mice are shown
relative to normalized day 0 (day of ﬁrst appearance of anxiety-related behavior). Each symbol represents results from a different mouse. The appearance of anxiety-related
behavior was deﬁned as a reduction in the percentage of photobeam crossings in the light room below the average value minus 2 SD of wild-type mice (the horizontal dashed
line).  C. Valproic acid (VPA), an antiepileptic drug, suppressed the onset of anxiety-related behavior in Snap25S187A/S187A mice. C-1, Typical traces of wild-type (Wt) and
Snap25S187A/S187A mice in the light–dark preference test with (+VPA) or without (−VPA) administration of VPA beginning 16 days after birth. C-2, Percentage of photobeam
crossings in the light room in wild-type (Wt) and Snap25S187A/S187A mice with or without VPA at the ages of 37 and 35 days, respectively. C-3, Typical traces of wild-type (Wt)
and  Snap25S187A/S187A mice in the open-ﬁeld test with (+VPA) or without (−VPA) administration. C-4, Percentage of distance traveled in the central area in wild-type (Wt) and
Snap25S187A/S187A mice with or without VPA at the ages of 35 and 37 days, respectively. **p < 0.01 between with and without VPA, with two-way ANOVA with Tukey-Kramer’s
h sis.
S
2
a
r
s
c
p
s
p
f
i
w
n
s
e
S
t
d
Gonestly signiﬁcant difference post-hoc test. Number of mice are shown in parenthe
WDs despite this reduced expression of SNAP-25 (Corradini et al.,
014). These results suggest that a decline in SNAP-25 expression
lone is not sufﬁcient for the appearance of SWDs, and additional
isk factors may  be necessary. The PKC-dependent phosphorylation
ite is mutated in Snap25S187A/S187A mice. Interestingly, the missing
hromosomal region in Coloboma mice contains a gene encoding
hospholipase C1, which generates diacylglycerol, a second mes-
enger that activates PKC. Thus, concomitant reductions in SNAP-25
rotein and PKC-dependent signaling activity are likely essential
or the appearance of SWDs. T-type Ca channels play a critical role
n the expression of SWDs. However, none of the mutant animals
ith SWDs has a mutation in the gene encoding the T-type Ca chan-
el itself (Crunelli and Leresche, 2002; Chen et al., 2014). Further
tudies are necessary to determine how various mutant proteins
nhance T-type Ca channel activity in these mutant animals and
nap25S187A/S187A mice.The second and third types of seizures were GSs appeared in
wo distinct periods. The onset of the ﬁrst period was 23.1 ± 3.6
ays after birth and lasted for 41.3 ± 14.8 h. After a latent period,
Ss reappeared during the second GS period. Unlike the ﬁrst GSperiod, generation of GSs during the second GS period continued
throughout the mouse’s entire life with cyclical changes in the
number of GSs. Two possibilities can be considered for the relation-
ship between GSs in the ﬁrst and second GS periods. First, some
inhibitory mechanism may  have converted the ﬁrst GS period to
the latent period, and this was terminated at the end of the latent
period. Thus, GSs appeared again during the second GS period.
Second, repeated GSs during the ﬁrst GS period may  have been
an “initial precipitating injury” (Mathern et al., 2002), similar to
status epilepticus in the pilocarpine and kainic acid models, induc-
ing spontaneous GSs during the second GS period. The second
possibility appears more probable because the sequential process
after the ﬁrst GS period resembles that in the pilocarpine and
kainic acid models (Curia et al., 2008), although further studies are
needed.
As described above, the expression level of SNAP-25 in
Snap25S187A/S187A mice is half that in wild-type mice. No GSs are
observed in heterozygous Coloboma or Snap25 knock-out mice
(Zhang et al., 2004; Corradini et al., 2014), in which the expres-
sion level of SNAP-25 is also half that in wild-type mice. Thus,
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pontaneous GSs are not only due to a reduction in SNAP-25 pro-
ein. SNAP-25 has two splice variants, SNAP-25a and SNAP-25b.
NAP-25a is inferior to SNAP-25b for supporting synchronous neu-
otransmitter release (Sorensen et al., 2003; Delgado-Martinez
t al., 2007). Tkneo-containing SNAP-25b-deﬁcient mice express
nly 80% of the normal SNAP-25 level and exhibit many epilep-
ic seizures by two weeks after birth. However, removal of the
election gene Tkneo reduces the severity of the phenotype,
nd spontaneous seizures occur less frequently and not prior to
oung adulthood (Johansson et al., 2008). Because PKC-dependent
NAP-25 phosphorylation is likely to involve enhanced exocytotic
ctivity, reduced expression and activity of SNAP25 likely syner-
istically contributed to the expression of GSs. Recently, a human
atient with severe generalized epilepsy was reported to have the
enetic mutation V48F in SNAP-25 (Rohena et al., 2013). Deter-
ining whether the mutation affects the expression level and/or
unction of SNAP-25 will be very interesting.
PKC-dependent SNAP-25 phosphorylation is involved in reg-
lation of neurotransmitter release by exocytosis, and dopamine
nd serotonin release is markedly reduced in the amygdala
f phosphorylation site-deﬁcient Snap25S187A/S187A mice (Kataoka
t al., 2011). Because -aminobutyric acid and serotonin suppress
pilepsy (Bagdy et al., 2007), inadequate regulation of release of
hese neurotransmitters may  cause epilepsy. On the other hand,
NAP-25 is also involved in incorporation of some ion channels
nd receptors into the plasma membrane by exocytosis (Jarvis and
amponi, 2007; Pozzi et al., 2008; Selak et al., 2009; Lau et al.,
010) and regulation of ion channel function through direct bind-
ng (Jarvis and Zamponi, 2007). SNAP-25 phosphorylation regulates
he incorporation of Ca channels and glutamate receptors into the
lasma membrane (Pozzi et al., 2008; Lau et al., 2010), and thus,
bnormal distribution of ion channels and/or receptors due to a
utant SNAP-25 phosphorylation site may  cause epileptic dis-
harges and seizures. Further studies are necessary to test these
ypotheses.
rocess of epileptogenesis
In the present study, we conducted continuous video-EEG
ecordings beginning in three-week-old mice and successfully
ecorded the process of epileptogenesis. Generation of GSs during
he ﬁrst GS period automatically stopped within 41.3 ± 14.8 h, sug-
esting that some suppressive mechanism initiated the shift to the
ubsequent latent period. Suppression seizures, which we observed
n the hippocampus (see also Figure 3), may  be a possible mech-
nism for the suppression. Determination of the mechanism and
hysiological signiﬁcance of suppression seizures will be necessary
n future studies.
In human patients, the interval between brain injury and
he ﬁrst spontaneous seizure can range from months to years
Annegers et al., 1998). A seizure-free latent period following the
initial precipitating injury” has been reported in various ani-
al  models of acquired epilepsy (Dudek and Staley, 2011a, b). In
arly studies with non-continuous video-EEG recording, the mean
atency period was estimated between 10 and 18 days. However,
ecent studies using continuous video-EEG monitoring demon-
trated that the ﬁrst spontaneous seizure occurs within a few
ays after status epilepticus (Raol et al., 2006; Gofﬁn et al., 2007;
umanglag and Sloviter, 2008). Using continuous video-EEG moni-
oring, we found a seizure-free latent period in all Snap25S187A/S187A
ice, despite individual differences in the duration. We  also found
hat the latent period consisted of at least three different periods,
he post-GS hyper-activated period, the quiet period, and the
eactivated period. Two hypothesis have been suggested for the
evelopment of epilepsy, a step function and a continuous-functionsearch 115 (2015) 30–44
hypothesis (Williams et al., 2009; Dudek and Stanley, 2011a, b). Our
current study is more consistent with the latter possibility.
Epileptic maturation
Although discussion remains, many clinical observations have
suggested that human temporal lobe epilepsy is often progressive
(Pitkänen and Sutula, 2002; Blume, 2006). In many animal models
of epilepsy, the frequency of seizures increases over time (Bertram
and Cornett, 1993, 1994; Hellier et al., 1998; Nissinen et al., 2000;
Williams et al., 2004; Kadam and Dudek, 2007; Williams et al.,
2009; Kadam et al., 2010). However, several opposite reports have
been published (Gorter et al., 2001; Bortel et al., 2010), and a gen-
eral consensus has not been obtained. Here we  showed distinct
progressive changes in the frequency, duration time, waveform of
seizures, and epileptic spikes during slow-wave sleep, over 10 or
more weeks after birth. Because these changes did not occur coin-
cidentally, several different mechanisms seem to underlie these
progressive changes.
In pilocarpine- and kainic acid-induced epileptic model mice,
a profound sprouting of mossy ﬁbers occurs, and NPY immunore-
activity appears in the inner molecular layer of the dentate gyrus
of the hippocampus as early as 10 days after status epilepticus
(Scharfman et al., 2000; Borges et al., 2003). We  observed vari-
ous changes in brain structure, including mossy ﬁber sprouting,
reactive astrocytosis, and upregulation of BDNF in Snap25S187A/S187A
mice, but further studies are needed to determine the molecular
and cellular basis of progressive changes in epileptic maturation.
Appearance of anxiety-like behaviors
In human epileptic patients, anxiety and its related psy-
chopathological conditions are widely observed (Kanner, 2004).
Anxiety-like behaviors and cognitive deﬁcits appear in animal mod-
els of epilepsy induced by pilocarpine and kainic acid treatment.
However, the process has not been studied precisely because these
behavior tests were conducted several weeks or months after sta-
tus epilepticus began (Gröticke et al., 2007; Müller et al., 2009). In
the present study, we found that anxiety-like behavior appeared
only a couple of days after repeated GSs began. Furthermore, we
found that the appearance of the anxiety-like behavior was sig-
niﬁcantly delayed by administration of VPA. These results indicate
that the appearance of anxiety-like behavior and the progression of
epilepsy occurred through distinct changes in brain structure, the
former was rapid changes induced by repeated GSs and the latter
was slower changes followed by repeated GSs.
Utility of Snap25S187A/S187A mice as an animal model of epilepsy
Epilepsy is a heterogeneous disorder with multiple origins, and
many mechanisms of pathogenesis exist among patients. Thus,
multiple animal models with different origins and phenotypes are
necessary for understanding epileptogenesis and epileptic matura-
tion. Snap25S187A/S187A mice have various advantages as an animal
model of epilepsy. First, preparation of a large number of homozy-
gous mice with in vitro fertilization is easy. Second, despite severe
GSs throughout the entire lifespan of the mice, mortality is quite
low, and most mice survive nearly 2 years (Kataoka et al., 2011).
Thus, Snap25S187A/S187A mice will be useful for screening of AEDs,
and observing the effects of various AEDs given at various times
during epileptogenesis and epileptic maturation will be interesting.Acknowledgments
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